177 related articles for article (PubMed ID: 12454773)
21. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
22. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
[TBL] [Abstract][Full Text] [Related]
23. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.
Robertson GP; Furnari FB; Miele ME; Glendening MJ; Welch DR; Fountain JW; Lugo TG; Huang HJ; Cavenee WK
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9418-23. PubMed ID: 9689095
[TBL] [Abstract][Full Text] [Related]
24. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
[TBL] [Abstract][Full Text] [Related]
25. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
[TBL] [Abstract][Full Text] [Related]
27. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
[TBL] [Abstract][Full Text] [Related]
29. PTEN/MMAC1 expression in esophageal squamous cell carcinomas.
Ding Y; Shimada Y; Kano M; Itami A; Kawabe A; Maeda M; Li Z; Hong T; Sato F; Kaganoi J; Imamura M
Int J Oncol; 2000 Oct; 17(4):695-9. PubMed ID: 10995879
[TBL] [Abstract][Full Text] [Related]
30. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
[TBL] [Abstract][Full Text] [Related]
31. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.
Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
34. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
Moritake H; Horii Y; Kuroda H; Sugimoto T
Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
[TBL] [Abstract][Full Text] [Related]
35. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
[TBL] [Abstract][Full Text] [Related]
36. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
Dong JT; Li CL; Sipe TW; Frierson HF
Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutation of PTEN in bladder carcinoma.
Aveyard JS; Skilleter A; Habuchi T; Knowles MA
Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
